High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy

Published:2013-02 Issue:3 Volume:49 Page:741-751
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Luo Yi,Chihara Yoshitomo,Fujimoto Kiyohide,Sasahira Tomonori,Kuwada Masaomi,Fujiwara Rina,Fujii Kiyomu,Ohmori Hitoshi,Kuniyasu Hiroki

Funder

Japan Society for the Promotion of Science, Japan

Ministry of Health, Labour and Welfare, Japan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer;Ohmori;Expert Opin Ther Targets,2011

2. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation;Scaffidi;Nature,2002

3. Characterization of cDNA sequences corresponding to three distinct HMG-1 mRNA species in line CHO Chinese hamster cells and cell cycle expression of the HMG-1 gene;Lee;Nucleic Acids Res,1987

4. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons;Rauvala;J Biol Chem,1987

5. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation;Parkkinen;J Biol Chem,1993

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression;CURR NEUROVASC RES;2024

2. Epigenetic regulation of autophagy by non-coding RNAs and exosomal non-coding RNAs in colorectal cancer: A narrative review;International Journal of Biological Macromolecules;2024-07

3. HMGB1 Signaling-Mediated Tumor Immunity in Cancer Progress;Frontiers in Bioscience-Landmark;2023-10-24

4. Crocetin: A Promising Adjunctive Therapy Enhancing Temozolomide Efficacy in Malignant Glioblastoma through Suppression of AKT, ERK, and p38 Signaling Pathways;2023-10-04

5. Using immunogenic cell death to improve anticancer efficacy of immune checkpoint inhibitors: From basic science to clinical application;Immunological Reviews;2023-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3